English | 中文  
           About Us | Services | Generics & Intermediates | Specialty Chemicals | Impurities & Metabolites | Patents | Publications | Join Us | Contact
Specialty Chemicals for Chemisty Specialists. Reliable Source of Moleculues from 10 mg to 10 mt.
  Atracurium impurity
 

ATRC01 (A1 in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-[[5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl]-1-oxopropoxy]pentyl]oxy]-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,trans-

ATRC02 (A2 in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-[[5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl]-1-oxopropoxy]pentyl]oxy]-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, cis -

ATRC03 (B in EP)
2(1H)-Isoquinolinepropanoic acid, 1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-, 1,1'-(1,5-pentanediyl) ester
[64228-77-9]

ATRC04 (C1 in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2-[3-oxo-3-[[5-[(1-oxo-2-propenyl)oxy]pentyl]oxy]propyl]-, trans-

ATRC05 (C2 in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2-[3-oxo-3-[[5-[(1-oxo-2-propenyl)oxy]pentyl]oxy]propyl]-, cis-
[119403-01-9 ]

 

ATRC06 (D1 in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-2-[3-[(5-hydroxypentyl)oxy]-3-oxopropyl]-6,7-dimethoxy-2-methyl-, trans-
[119402-98-1]

ATRC07 (D2 in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-2-[3-[(5-hydroxypentyl)oxy]-3-oxopropyl]-6,7-dimethoxy-2-methyl-, cis-

ATRC08 (E in EP)
Isoquinolinium, 2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-
[99469-29-1 ]

ATRC09 (F in EP)
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2,2-dimethyl-
[34866-20-1 ]

ATRC10 (G in EP)
Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-
[1699-51-0 ]

ATRC11 (H1 in EP)
Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, [1R-[1α,2β(1'R*,2'S*)]]-
 [96946-45-1]

ATRC12 (H2 in EP)
Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'R,2R,2'R)-
[96946-41-7 ]

ATRC13 (I1 in EP)
Isoquinolinium, 2,2'-[(3-methyl-1,5-pentanediyl)bis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'R,2S,2'S)-
ATRC14 (I2 in EP)
Isoquinolinium, 2,2'-[(3-methyl-1,5-pentanediyl)bis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'R,2R,2'R)-
[1193104-79-8]
ATRC15 (K in EP)
Isoquinolinium, 2,2'-[(1-methyl-1,5-pentanediyl)bis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'R,2R,2'R)-
 [1193104-81-2]
ATRC16
Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (1S), L-Leucine, N-acetyl-
 [50720-57-5]
ATRC17
Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R)-
 [85-63-2]
ATRC18
2(1H)-Isoquinolinepropanoic acid, 1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-, 2,2'-(1,5-pentanediyl) ester, (1R,1'R)-, ethanedioate (1:1)
 [1248429-33-5 ] (Component:64228-84-8)
ATRC19
2(1H)-Isoquinolinepropanoic acid, 1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-, phenylmethyl ester, (1R)-
[1075726-78-1]
ATRC20
Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-2-[3-oxo-3-(phenylmethoxy)propyl]-, (1R,2S)-
[1075726-97-4]

It will be provided for research purpose use only, if the chemical listed here is of potential infringing with the intellectual property rights of any other party in certain areas.

 

 
Copyright © 2009 Topharman Shanghai Co., Ltd. All Rights Reserved.